# Product Owner Decision Record: PO-2026-08-23

**Date:** 2026-08-23  
**Decision owner:** UberTib product owner  
**Status:** Approved provisional baseline  
**Source type:** Direct answers to the requirements and architecture clarification set

## Confirmed Decisions

1. The product owner accepted the architect's recommended interpretation for the first clarification.
2. All proposed service and configuration items are in scope. Their current defaults are versioned, provisional, and replaceable after customer review.
3. The provisional S/P/H/I calculation must first use evidence found in the project and authoritative medical or comparable-product sources where the project is silent. Its formula, weights, thresholds, and bands remain configurable and prospectively replaceable after the customer observes the complete behavior.
4. The proposed interim behavior is accepted until customer review of the complete flow.
5. The architect may select the technically appropriate option consistent with the product's features and direction.
6. The architect may resolve clarifications 6 through 8 to preserve a good user experience, the project's core direction, and its intended purpose.
7. Initial operating scope is Aleppo, with a planning envelope of low thousands of users.
8. Comparable applications and reliable medical sources may inform provisional decisions but do not override the authoritative SRS or licensed clinical review.
9. V1 performs no electronic payment or money movement. It records external financial events and their confirmation or dispute so the operating team can review them and act offline. It is a financial-management record system, not a payment or funds system.

## Governance Conditions

- The approved SRS remains authoritative.
- Defaults and evaluation catalog values are provisional until customer and, where clinical, licensed medical review.
- Configuration changes apply prospectively; historical decisions retain their captured policy and data snapshots.
- Research and comparable-product behavior may support clinical review but cannot transfer diagnosis or clinical approval to the platform.

## Implementation Consequence

This decision authorizes the planning baseline, configurable defaults, Aleppo-first capacity assumptions, clinical launch gate, evaluation-only catalog, and record-only financial boundary. It does not approve final production catalog content, clinical values, electronic payments, or UI/UX decisions.
